DIA 48th Annual Meeting
Click here to go to the previous page
Infliximab Risk Evaluation and Mitigation Strategy: Embarking and Executing on the New Era in Drug Safety
Track
:
Professional Poster Session 1, Tuesday June 26, 2012
Program Code:
T16
PRESENTER
:
Brenda Sarokhan, Centocor Ortho Biotech Products, LLC, United States